Radiofrequency for the Treatment of Allergic Rhinitis Refractory to Medical Therapy

Lin, Hsin‐Ching; Lin, Pei‐Wen; Su, Chih‐Ying; Chang, Hsueh‐Wen

doi:10.1097/00005537-200304000-00017

Cited by 64 publications

(73 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…RFT has been found effective in patient with AR subjectively [19]. This study confirmed the safety and efficacy of RFT for the treatment of nasal congestion due to inferior turbinate hypertrophy in patients with PAR both objectively and subjectively.…”

Section: Discussionsupporting

confidence: 76%

Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters

Günhan

Ünlü

Yücetürk

et al. 2010

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Nasal congestion is a cardinal symptom of allergic rhinitis (AR). It is associated with decreased quality of life and difficult to treat as perceived by the patients. The purpose of this study is to evaluate the mid-term objective and subjective outcomes of management of nasal congestion using intranasal steroid (INS) therapy or radiofrequency turbinoplasty (RFT) in patients with persistent AR who have mucosal hypertrophy of the inferior turbinate. Fifty-five adult patients with AR, who claimed nasal congestion refractory to oral antihistamine (desloratadine) therapy, were randomized to INS (mometasone furoate) or temperature-controlled RFT treatment groups. Outcomes were determined by active anterior rhinomanometry, visual analog scale (VAS), and rhinoconjunctivitis quality of life questionnaire (RQLQ) at least 12 months after treatment. The median total nasal resistance decreased from 0.49 ± 0.17 to 0.39 ± 0.12 Pa/cm(3)/s (p = 0.42), and from 0.51 ± 0.18 to 0.29 ± 0.07 Pa/cm(3)/s (p = 0.003) with INS and RFT, respectively. RFT provided a better reduction in the perception of congestion in VAS scores. RQLQ scores improved significantly in both groups 1 year after treatment (mean follow-up 14.2 months) (p < 0.05). No adverse reactions were encountered in either group. Nasal congestion refractory to antihistamine appears to be improved by INS at some point, while reduced significantly by RFT in objective and subjective parameters. Both options are also effective in increasing the quality of life in patients with AR. RFT might be a safe and effective treatment of option in AR compared with INS.

show abstract

Section: Discussionsupporting

confidence: 76%

Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters

Günhan

Ünlü

Yücetürk

et al. 2010

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

“…Mild pain controlled with over the counter analgesics has also been reported (12 %). Numbness of the maxillary teeth is another reported transient side effect of radiofrequency turbinate reduction [11], but was not seen in our study.…”

Section: Discussioncontrasting

confidence: 79%

Comparative Study of Response Through Reduction in the Size of Hypertrophied Inferior Turbinate Causing Nasal Obstruction by Different Surgical Modalities: A Prospective Study

Dhulipalla¹

2014

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

Inferior turbinate hypertrophy is one of the major causes of nasal airway obstruction. Medical treatment often produces insufficient improvement. In these cases, surgical reduction of inferior turbinate can be proposed. Many different techniques are currently available. The aim of our study is to prospectively evaluate the effectiveness of three techniques i.e., electrocautery, cryotherapy and radiofrequency by comparing the response of patients to these three surgical modalities of turbinate reduction. A total of 90 patients presenting with nasal obstruction with or without allergic symptoms, fulfilling the inclusion and exclusion criteria, attending ENT OPD are included in the study. A prospective study was conducted on three groups of thirty patients with symptoms and signs of nasal obstruction associated with inferior turbinate hypertrophy of more than 3 months duration. Then the percentage of subjective improvement in nasal airway is used to assess treatment outcomes 1week, 1, 3, 6, 9 and 12 months after surgery. At the end of 12 months, 56.6 % of patients treated with electrocautery and 56.6 % of patients treated with cryotherapy showed 75 % improvement in nasal obstruction whereas 59.99 % of patients treated with radiofrequency showed 100 % improvement. No statistical difference in the amount of improvement in nasal obstruction was noted between the three treatment groups at the end of 12 months because of relatively small sample size. But clinically radiofrequency showed better subjective improvement in nasal obstruction when compared to cryotherapy and electrocautery.

show abstract

“…7 Most of the published literature on RF turbinate surgery has a relatively short follow-up. However, only long-term studies will ultimately determine whether this novel strategy results in valuable outcomes.…”

mentioning

confidence: 99%

Long-term Results of Radiofrequency Turbinoplasty for Allergic Rhinitis Refractory to Medical Therapy

Lin¹,

Lin²,

Friedman³

et al. 2010

Arch Otolaryngol Head Neck Surg

Self Cite

View full text Add to dashboard Cite

show abstract

Radiofrequency for the Treatment of Allergic Rhinitis Refractory to Medical Therapy

Cited by 64 publications

References 22 publications

Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters

Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters

Comparative Study of Response Through Reduction in the Size of Hypertrophied Inferior Turbinate Causing Nasal Obstruction by Different Surgical Modalities: A Prospective Study

Long-term Results of Radiofrequency Turbinoplasty for Allergic Rhinitis Refractory to Medical Therapy

Contact Info

Product

Resources

About